BioCentury | Jul 28, 2016
Distillery Therapeutics

Therapeutics: Transmembrane 4 L six family member 1 (TM4SF1); discoidin domain receptor tyrosine kinase 1 (DDR1); signal transducer and activator of transcripti

...include identifying inhibitors of TM4SF1, its interaction with DDR1 or its downstream signaling activity. TARGET/MARKER/PATHWAY: Transmembrane 4 L six family member 1...
BioCentury | Jun 19, 2014
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Liver cancer Transmembrane 4 L six family member 5 (TM4SF5) Studies in patient samples, cell culture and mice suggest antagonizing TM4SF5 could help treat hepatocellular...
BioCentury | Apr 10, 2008
Distillery Therapeutics

This Week in Therapeutics

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Liver cancer Transmembrane 4 L six family member 5 (TM4SF5) Studies of hepatocytes in vitro and in mice suggest that targeting...
Items per page:
1 - 3 of 3